Home > Insider Trading > Filing (0001209191-16-129131)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368148	Athersys Inc / New	ATHX	Pharmaceutical Preparations (2834)	204864095

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402609	Jr William Lehmann	3201 Carnegie Avenue Cleveland OH 44115-2634	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-06-17	15,703	$2.16	279,017	No	4	F	Direct
Common Stock	Acquisiton	2016-06-20	154,800	$0.00	433,817	No	4	A	Direct
Common Stock	Disposition	2016-06-20	13,000	$2.18	420,817	No	4	S	Direct
Common Stock	Disposition	2016-06-21	12,000	$2.16	408,817	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to purchase)	Acquisiton	2016-06-20	361,200	$0.00	361,200	$2.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
361,200		2026-06-20	No	4	A	Direct

Footnotes

Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award related to the minimum tax withholding obligation.
Award of annual restricted stock units, each of which represents a contingent right to receive one share of Athersys, Inc. common stock after vesting. The restricted stock units vest ratably on a quarterly basis over a four-year period.
Shares sold pursuant to a predefined Rule 10b5-1 trading plan for tax and planning purposes related to the quarterly vesting of a June 2013 restricted stock unit award.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.20, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.135 to $2.20, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
Securities beneficially owned are comprised of: (1) 187,849 shares of common stock owned and (2) unvested restricted stock units aggregating 220,968 related to annual awards, which vest quarterly over a four-year period from grant date.
Award of an annual stock option. The option vests ratably on a quarterly basis over a four-year period.